Clinical Trial Update: Enteral High-dose DHA Supplementation on Bronchopulmonary Dysplasia in Very Preterm Infants: a Collaborative Study [NA]

View source ↗

Summary

Clinical trial update on enteral high-dose docosahexaenoic acid (DHA) supplementation for bronchopulmonary dysplasia in very preterm infants; the study status i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• DHA (docosahexaenoic acid) (docosahexaenoic acid)

Snippet

Sponsor: CHU de Quebec-Universite Laval | Conditions: Bronchopulmonary Dysplasia, Child Development | NA | Status: ACTIVE_NOT_RECRUITING